AP
NPTN

AHL Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

AHL Partners’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-22,771
Closed -$205K – 1262
2017
Q1 		$205K Buy
22,771
+2,117
+10% +$22.1K ﹤0.01% 1152
2016
Q4 		$223K Buy
+20,654
New +$275K 0.01% 1003

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AHL Partners's NPTN Position: Q2 2017 in Review

AHL Partners sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 22,771 shares — an estimated $205K sold.

AHL Partners first reported a position in NPTN in Q4 2016 and held it in 2 quarters. The position peaked at $223K in Q4 2016. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

  • AHL Partners reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
  • AHL Partners sold 22,771 NEOPHOTONICS CORP shares in Q2 2017, an estimated $205K.
  • AHL Partners first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 2 quarters.
  • AHL Partners's NEOPHOTONICS CORP position peaked at $223K in Q4 2016.
  • 101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on AHL Partners's 13F filing for Q2 2017, filed 14 Aug 2017.